Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Erythromycin

Known as: (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, Erythromycine, Erythromycin [Chemical/Ingredient] 
A broad-spectrum, macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
ABSTRACT A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection caused by a… Expand
Highly Cited
2006
Highly Cited
2006
BACKGROUND Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the… Expand
  • table 1
  • table 2
  • table 3
Review
2002
Review
2002
  • R. Leclercq
  • Clinical infectious diseases : an official…
  • 2002
  • Corpus ID: 14714107
Resistance to macrolides and lincosamides is increasingly reported in clinical isolates of gram-positive bacteria. The… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Review
2000
Review
2000
  • M. Cunningham
  • Clinical microbiology reviews
  • 2000
  • Corpus ID: 22526471
Group A streptococci are model extracellular gram-positive pathogens responsible for pharyngitis, impetigo, rheumatic fever, and… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
Diffuse panbronchiolitis (DPB) is a chronic inflammatory disease of the airways with a high rate of mortality despite treatment… Expand
Highly Cited
1997
Highly Cited
1997
BACKGROUND In the early 1990s there was an increase in erythromycin resistance among group A streptococci in Finland. In response… Expand
Highly Cited
1996
Highly Cited
1996
Erythromycin resistance determinants include Erm methylases, efflux pumps, and inactivating enzymes. To distinguish the different… Expand
Review
1995
Review
1995
  • B. Weisblum
  • Antimicrobial agents and chemotherapy
  • 1995
  • Corpus ID: 2951780
Erythromycin inhibits protein synthesis by its effect on ribosome function (14, 118, 119). The metabolic modifications that… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • figure 2
Highly Cited
1995
Highly Cited
1995
BACKGROUND Pregnant women with bacterial vaginosis may be at increased risk for preterm delivery. We investigated whether… Expand
Highly Cited
1990
Highly Cited
1990
ERYTHROMYCIN A, a clinically important polyketide antibiotic, is produced by the Gram-positive bacterium Saccharopolyspora… Expand